Times LIVE (blog) Egrifta Gets FDA Approval for HIV-Associated Lipodystrophy AIDSmeds.com HIV/AIDS Treatment News The drug, requiring once-daily injections, was approved to reduce visceral adipose tissue (VAT)— deep belly fat surrounding the liver, stomach and other ... FDA Approves Egrifta For Treatment Of Lipodystrophy In People With HIV The AIDS Beacon Theratechnologies' Drug To Treat Lipodystrophy Gets FDA Approval Stock Markets Review all 103 news articles?? Read more »
FDA Panel Gives Thumbs Up for Egrifta – Medscape
TopNews United Kingdom (blog) FDA Panel Gives Thumbs Up for Egrifta Medscape ... to live with the unsightly accumulation of belly fat — an adverse effect of antiretroviral therapy — that immediately labeled them as "AIDS patients Read more »
